Successful maternal and fetal outcome of pregnancy following heart valve replacement using a sequential anti coagulation regime

Pooja Tandon; Suman Puri; Balpreet Kaur; Shreeswasti Chaondwal; Supriya Gupta

doi:10.18203/2320-1770.ijrcog20150095

Authors

Pooja Tandon Department of Obstetrics & Gynaecology, DMC&H, Ludhiana, Punjab, India
Suman Puri Department of Obstetrics & Gynaecology, DMC&H, Ludhiana, Punjab, India
Balpreet Kaur Department of Obstetrics & Gynaecology, DMC&H, Ludhiana, Punjab, India
Shreeswasti Chaondwal Department of Obstetrics & Gynaecology, DMC&H, Ludhiana, Punjab, India
Supriya Gupta Department of Obstetrics & Gynaecology, DMC&H, Ludhiana, Punjab, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20150095

Keywords:

Heart valve replacement, Pregnancy, Anticoagulant

Abstract

Background: Patients with mechanical heart valves require anticoagulation which is associated with significant maternal mortality (1-4%) and fetal complications (31%) in pregnancy.

Methods: A prospective study was carried out enrolling pregnant patients with mechanical heart valves who were booked at our institution for antenatal care, managed using a sequential anticoagulant regime consisting of warfarin and low molecular weight heparin and delivered at our utility over two years.

Results: We had seven cases of pregnancy following heart valve replacement over a period of two years with no fetal malformations and successful maternal outcome (71.43% term deliveries).

Conclusions: LMWH until 13^th week of gestation, followed by warfarin until late third trimester (36 weeks), then restarting LMWH until delivery in pregnant patients with mechanical heart valves was associated with successful maternal and fetal outcome.

Metrics

Metrics Loading ...

References

Oakley CM. Anticoagulants in pregnancy. Br Heart J. 1995;74:107-11.

Badduke ER, Jamieson WRE, Miyashima RT, Munro AI, Gerein AN, MacNab J, et al. Pregnancy and childbearing in a population with biologic valvular prostheses. J Thorac Cardiovasc Surg. 1991;102:179-86.

Oakley CM. Valve prostheses and pregnancy. Br Heart J. 1987;58:303-5.

Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68:122-40.

Ferraris VA, Klingman RR, Dunn L, Fein S, Eglowstein M, Samelson R. Home heparin therapy used in a pregnant patient with a mechanical heart valve prosthesis. Ann Thorac Surg. 1994;581168-70.

Golby AJ, Bush EC, DeRook FA, Albers GW. Failure of high dose heparin to prevent recurrent cardioembolic strokes in a pregnant patient with a mechanical heart valve. Neurology. 1992;42:2204-6.

Watson WJ, Freeman J, O’Brien C, Benson M. Embolic stroke in a pregnant patient with a mechanical heart valve on optimal heparin therapy. Am J Perinatol. 1996;36:371-2.

Hurwitz A, Milwidsky A, Medina A, Yagel S. Failure of continuous intravenous heparinization to prevent stroke in a pregnant woman with a prosthetic valve and atrial fibrillation. J Reprod Med. 1985;30:618-20.

Sareli P, England MJ, Berk MR, Marcus RH, Epstein M, Driscoll J, et al. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol. 1989;63:1462-5.

Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33:1637-41.

Bonow RO, Carabello BA, Chatterjee K, de Leon A Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Col Cardiol. 2006;48:e1-148.

Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-68.